Presentation TCT 2016 TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante October 31, 2016
Presentation TCT 2016 TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori October 31, 2016
News Conference News TCT 2016 EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo. Michael O'Riordan October 31, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
Presentation TCT 2016 TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned? Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials Presenter: Jung-Min Ahn October 30, 2016
Presentation TCT 2016 Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study Presenter: Peter Juni, E. Magnus Ohman, Ori Ben-Yehuda October 30, 2016
Presentation TCT 2016 Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys October 30, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
Presentation TCT 2015 PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose Presenter: Davide Capodanno, Gregg W. Stone, Patrick W. Serruys October 15, 2015
Presentation TCT 2015 Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta October 14, 2015
Presentation TCT 2015 Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta October 14, 2015
News Conference News TCT 2015 TUXEDO-India Affirms Superiority of EES in Patients With Diabetes Todd Neale October 14, 2015
Presentation TCT 2015 TCT 18: Impact of Incomplete Revascularization After Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease A SEEDS Substudy Presenter: Eric A. Cohen, Truls Råmunddal, Nicolas Bettingeer October 13, 2015
News Conference News TCT 2015 Trial Results Often Struggle to Keep Pace With Evolving Technology Nicole Lou October 13, 2015
News Conference News TCT 2015 RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization Yael L. Maxwell October 13, 2015
News Conference News TCT 2015 EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function Todd Neale October 13, 2015
Presentation TCT 2015 Physiological Assessment in Multivessel Disease: What Will SYNTAX 2 and FAME 3 Tell Us? Presenter: Sergio B Baptista, Eric Van Belle, Bernard De Bruyne October 12, 2015
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane October 12, 2015